The impact of chronic hepatitis C on resource utilisation and in-patient mortality for Medicare beneficiaries between 2005 and 2010

被引:29
|
作者
Younossi, Z. M. [1 ,2 ]
Stepanova, M. [2 ]
Mishra, A. [1 ]
Venkatesan, C. [1 ]
Henry, L. [2 ]
Hunt, S. [1 ,2 ]
机构
[1] Inova Fairfax Hosp, Dept Med, Falls Church, VA USA
[2] Inova Hlth Syst, Betty & Guy Beatty Ctr Integrated Res, Falls Church, VA USA
关键词
QUALITY-OF-LIFE; DUAL ELIGIBLES; COST; EPIDEMIOLOGY; VIRUS;
D O I
10.1111/apt.12485
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BackgroundAs baby boomers age, chronic hepatitis C (CHC) will become increasingly important in Medicare eligible group. AimTo evaluate trends in Medicare resource utilisation for CHC. MethodsWe analysed the Medicare in-patient and out-patient data from 2005 to 2010. For each patient, all claims with CHC as a principal diagnosis were added up and yearly CHC-related spending was calculated. ResultsA total of 48880 out-patient claims for 21655 CHC patients and 4884 hospital admission claims for 3092 patients were included. The number of in-patient (1.5-1.6/year) or out-patient (2.2-2.3/year) visits per patient did not change over time, nor did the demographic characteristics of the CHC population. The majority of this population was eligible for Medicare based on disability and the average number of diagnoses per in-patient claim (from 8.11 in 2005 to 8.60 in 2010) and per out-patient claim (from 2.18 in 2005 to 2.71 in 2010) increased (both P<0.0001). The average total yearly spending per patient increased in the out-patient setting from $488 in 2005 to $584 in 2010 (P=0.0132) and did not change in the in-patient setting (from $22245 in 2005 to $23383 in 2010, P=0.14). In the multivariate analysis, the number of diagnoses and conditions per claim and the number of in-patient or out-patient procedures per year were the important independent predictors of increased resource utilisation. ConclusionsMost Medicare beneficiaries with chronic hepatitis C who sought in-patient or out-patient care in 2005-2010 had received Medicare for disability. Although the total resource utilisation did not change, the proportion of patient's responsibility increased.
引用
收藏
页码:1065 / 1075
页数:11
相关论文
共 50 条
  • [21] Impact of Chronic Hepatitis C Infection on Mortality in Chronic Hemodialysis Patients: A Meta-Analysis
    Salami, Augustine
    Ditah, Ivo C.
    Marupakula, Vidyasagar
    Jaiyeoba, Charles O.
    Bhat, Zeenat
    Jafri, Syed-Mohammed
    GASTROENTEROLOGY, 2012, 142 (05) : S966 - S966
  • [22] The impact of chronic hepatitis B and C on the functioning and well-being of the patient
    Stelmaszczyk, Iwona
    Mastalerz-Migas, Agnieszka
    FAMILY MEDICINE AND PRIMARY CARE REVIEW, 2013, 15 (02): : 170 - 172
  • [23] Focusing on the patient: impact of new UK guidelines on treatment of chronic hepatitis C
    Ramachandran, Prakash
    Hayes, Peter C.
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2012, 6 (03) : 259 - 261
  • [24] Racial/Ethnic and Socioeconomic Disparities in Use of Direct-Acting Antivirals Among Medicare Beneficiaries with Chronic Hepatitis C, 2014-2016
    Jung, Jeah
    Du, Ping
    Feldman, Roger
    Kong, Lan
    Riley, Thomas, III
    JOURNAL OF MANAGED CARE & SPECIALTY PHARMACY, 2019, 25 (11): : 1236 - 1242
  • [25] IMPACT OF PEGYLATED BITHERAPY ON MORBIDITY AND MORTALITY IN PATIENTS WITH CHRONIC HEPATITIS C AND NORMAL TRANSAMINASES
    Deuffic-Burban, Sylvie
    Lonjon-Domanec, Isabelle
    Babany, Gerard
    Deltenre, Pierre
    Louvet, Alexandre
    Canva, Valerie
    Dharancy, Sebastien
    Castel, Helene
    Rhoudot-Thoraval, Francoise
    Mathurin, Philippe
    HEPATOLOGY, 2008, 48 (04) : 892A - 892A
  • [26] Predictors of Inpatient Mortality and Resource Utilization for the Elderly Patients With Chronic Hepatitis C (CH-C) in the United States
    Suen, Winnie
    Otgonsuren, Munkhzul
    Koenig, Aaron B.
    Noor, Bashir
    Fang, Yun
    Younossi, Zobair M.
    GASTROENTEROLOGY, 2015, 148 (04) : S970 - S970
  • [27] Predictors of Inpatient Mortality and Resource Utilization for the Elderly Patients With Chronic Hepatitis C (CH-C) in the United States
    Golabi, Pegah
    Otgonsuren, Munkhzul
    Suen, Winnie
    Koenig, Aaron B.
    Noor, Bashir
    Younossi, Zobair M.
    MEDICINE, 2016, 95 (03)
  • [28] Mortality Among Persons in Care With Hepatitis C Virus Infection: The Chronic Hepatitis Cohort Study (CHeCS), 2006-2010
    Mahajan, Reena
    Xing, Jian
    Liu, Stephen J.
    Ly, Kathleen N.
    Moorman, Anne C.
    Rupp, Loralee
    Xu, Fujie
    Holmberg, Scott D.
    CLINICAL INFECTIOUS DISEASES, 2014, 58 (08) : 1055 - 1061
  • [29] Factors associated with medical resource utilisation and related costs in treatment-experienced patients with genotype 1 chronic hepatitis C
    Akpo, E.
    Sbarigia, U.
    Kleintjens, J.
    JOURNAL OF VIRAL HEPATITIS, 2014, 21 : 26 - 27
  • [30] Impact of eradication of hepatitis C virus on liver-related and -unrelated diseases: morbidity and mortality of chronic hepatitis C after SVR
    Mina Nakagawa
    Yasuhiro Asahina
    Sei Kakinuma
    Ryuichi Okamoto
    Journal of Gastroenterology, 2023, 58 : 299 - 310